Weyna; David R.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Weyna; David R..The latest application filed is for "novel crystalline forms".
- Weyna; David R. - Tampa FL
- Weyna; David R. - Lutz FL
| Patent | Date |
|---|---|
| Crystalline forms Grant 10,526,358 - Hanna , et al. J | 2020-01-07 |
| Crystalline forms Grant 10,519,176 - Hanna , et al. Dec | 2019-12-31 |
| Crystallization method and bioavailability Grant 10,323,052 - Hanna , et al. | 2019-06-18 |
| Novel Crystalline Forms App 20190144474 - HANNA; Mazen ; et al. | 2019-05-16 |
| Novel Crystalline Forms App 20190002483 - HANNA; Mazen ; et al. | 2019-01-03 |
| Crystallization Method And Bioavailability App 20180333425 - HANNA; Mazen ; et al. | 2018-11-22 |
| Crystallization method and bioavailability Grant 10,093,691 - Hanna , et al. October 9, 2 | 2018-10-09 |
| Oral forms of a phosphonic acid derivative Grant 9,682,091 - Hanna , et al. June 20, 2 | 2017-06-20 |
| Crystallization Method And Bioavailability App 20170022227 - HANNA; Mazen ; et al. | 2017-01-26 |
| Crystallization Method And Bioavailability App 20170022226 - HANNA; Mazen ; et al. | 2017-01-26 |
| Novel Crystalline Forms App 20170022225 - HANNA; Mazen ; et al. | 2017-01-26 |
| Crystalline forms Grant 9,340,565 - Hanna , et al. May 17, 2 | 2016-05-17 |
| Crystallization method and bioavailability Grant 9,334,296 - Hanna , et al. May 10, 2 | 2016-05-10 |
| Crystallization Method And Bioavailability App 20160016982 - HANNA; Mazen ; et al. | 2016-01-21 |
| Novel Oral Forms Of A Phosphonic Acid Derivative App 20150306116 - HANNA; Mazen ; et al. | 2015-10-29 |
| Crystallization method and bioavailability Grant 9,169,279 - Hanna , et al. October 27, 2 | 2015-10-27 |
| Crystalline molecular comlpexes of tadalafil Grant 9,040,535 - Hanna , et al. May 26, 2 | 2015-05-26 |
| Crystallization method and bioavailability Grant 8,933,057 - Hanna , et al. January 13, 2 | 2015-01-13 |
| Crystallization Method And Bioavailability App 20140107076 - HANNA; Mazen ; et al. | 2014-04-17 |
| Crystalization Of Pharmaceutical Compounds App 20140100233 - HANNA; Mazen ; et al. | 2014-04-10 |
| Crystallization Method And Bioavailability App 20140057875 - HANNA; Mazen ; et al. | 2014-02-27 |
| Novel Crystalline Forms App 20130316982 - Hanna; Mazen ; et al. | 2013-11-28 |
| Crystalline molecular complex of tadalafil and methylparaben Grant 8,586,587 - Hanna , et al. November 19, 2 | 2013-11-19 |
| In vivo studies of crystalline forms of meloxicam Grant 8,389,512 - Hanna , et al. March 5, 2 | 2013-03-05 |
| Crystallization Method And Bioavailability App 20130035315 - HANNA; Mazen ; et al. | 2013-02-07 |
| In Vivo Studies of Crystalline Forms of Meloxicam App 20120149692 - Hanna; Mazen ; et al. | 2012-06-14 |
| In vivo studies of crystalline forms of meloxicam Grant 8,124,603 - Hanna , et al. February 28, 2 | 2012-02-28 |
| Crystalization Of Pharmaceutical Compounds App 20120046297 - Hanna; Mazen ; et al. | 2012-02-23 |
| In vivo studies of crystalline forms of meloxicam App 20090203680 - Hanna; Mazen ; et al. | 2009-08-13 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 